The global home infusion therapy market is estimated to be valued at USD 26.18 Bn in 2025 and is expected to reach USD 41.49 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.
To learn more about this report, Download Free Sample
The home infusion therapy market is expected to witness high growth rate over the forecast period owing to the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. Rising geriatric population suffering from these conditions coupled with growing preference of patients to get treatment administered at home instead of hospitals or long-term care centers is a key factor expected to drive the demand for home infusion therapy. Additionally, rising health care costs have compelled patients to opt for low-cost treatment settings like home care which is further expected to support the market growth in the coming years.
|
Current Events |
Description and its impact |
|
Regulatory and Reimbursement Policy Shifts |
|
|
Technological Innovations and Adoption |
|
|
Market Consolidation and Competitive Dynamics |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Medicare’s Part B home infusion benefit, enacted under the 21st Century Cures Act and implemented in January 2021, covers professional services—such as nursing, training, and care coordination—only for drugs administered via a durable medical equipment (DME) pump. Also, commercial insurers routinely provide daily bundled reimbursement for all professional care associated with home infusions, enabling wider access and significant cost savings—literature reviews affirm that home infusion is as safe and effective as facility-based care and can reduce costs by approximately USD 2,000– USD 3,000 per treatment course.
Infusion Pumps segment is expected to contribute the highest share of the global home infusion therapy market with 40.7% in 2025 owing to their versatility and suitability for delivering a variety of therapies at home. Infusion pumps allow for precision in drug delivery directly into the body via an IV, offering patients greater autonomy and control over their treatment. The demand for infusion pumps is primarily driven by their widespread application in chemotherapy and diabetes treatment. For chemotherapy patients, infusion pumps enable convenient home-based administration of drugs over extended periods, significantly improving quality of life by reducing hospital visits. They also help regulate drug dosage more accurately compared to manual methods. Similarly, insulin-dependent diabetes patients rely on infusion pumps to maintain steady glucose levels outside of hospital settings. For instance, in April 2025, ICU Medical achieved new regulatory milestones that establish a new category for its infusion systems. These developments include the introduction of the Plum Solo precision IV pump, designed as a single-channel counterpart to the dual-channel Plum Duo. Such developments are propelling the home fusion therapy market revenue.
Chemotherapy is expected to account for the largest share of the home infusion therapy market with 30.62% in 2025 owing to the rising cancer prevalence and increasing shift towards home-based treatment. While hospital-based chemotherapy continues as the mainstream approach, many oncologists are now recommending interim home infusion to reduce clinic visits and improve patient comfort. The main advantages of home chemotherapy include avoidance of hospital-acquired infections, minimized disruptions to lifestyle and work, and more personalized care from family members. This is proving especially beneficial for older and palliative care patients requiring long-term treatment. With infusions being administered at a comfortable home setting by trained nurses, patients often experience less anxiety, pain and chemo-related side effects compared to clinical surroundings. For instance, Jivika Healthcare, a leading mobile medical service provider in India, has officially launched ChemoAtHome, a pioneering initiative aimed at delivering safe, high-quality chemotherapy treatment in the comfort of patients’ homes.
To learn more about this report, Download Free Sample
The North American home infusion therapy market is growing rapidly due to several important trends. The rise in chronic diseases like cancer and diabetes is driving increased demand for long-term infusion treatments. Advances in infusion devices, such as smart pumps and remote monitoring systems, improve treatment accuracy and patient safety. Additionally, the aging population and growing preference for home-based care are fueling home infusion therapy market demand.
For instance, AmerisourceBergen (AB) has launched a program to help hospitals and health systems start or enhance home infusion services. As site-of-care strategies gain importance, many systems are expanding into home infusion to maintain care continuity and support growing outpatient treatment options. AB’s program offers a step-by-step approach to help health systems build and run clinically focused, sustainable home infusion programs within their networks.
Fast aging populations in countries like China, India, and Japan are increasing the prevalence of chronic diseases that require long-term infusion treatments. This demographic shift is sharply driving up the demand for infusion therapy and other home-based healthcare services. Administering medication at home provides a cost-effective alternative to inpatient care, attracting patients and healthcare systems aiming to reduce costs without compromising quality.
Rising cases of chronic diseases such as diabetes, cardiovascular disease, and cancer are driving the demand for home infusion therapy. Patients often require continuous care and management, which healthcare providers can efficiently deliver at home. Recent innovations in infusion equipment, including portable pumps and advanced monitoring systems, have made home infusion therapy safer and more effective.
In February 2024, Hikma Pharmaceuticals PLC (Hikma), a multinational pharmaceutical company, has launched COMBOGESIC® IV injection in the US. This opioid-free intravenous pain relief medication combines 1,000 mg of acetaminophen with 300 mg of ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID).
China is experiencing a rise in chronic illnesses like diabetes, heart disease, and cancer. The National Health Commission reports that over 300 million people have diabetes, highlighting the growing demand for home-administered infusion therapies to manage these conditions effectively. Innovations such as smart delivery systems and computerized infusion pumps are making home infusion therapies safer and more effective. These devices improve patient outcomes and increase adoption by allowing real-time monitoring and remote adjustments.
To learn more about this report, Download Free Sample
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 26.18 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.8% | 2032 Value Projection: | USD 41.49 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical, CareCentrix, Inc., Coram CVS/specialty infusion services, Option Care Health Inc., CVS Health, UnitedHealth Group (Optum), McKesson Corporation, PharMerica Corporation, BioScrip, Inc., MedicoRx Specialty Pharmacy, Infusystem, Diplomat Pharmacy, Inc., Accredo Health Group, Inc., Healix, Inc., and PromptCare Home Infusion |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The development of portable, user-friendly infusion pumps equipped with smart features is enhancing the accessibility and efficiency of home infusion therapy. Modern devices often include wireless connectivity, enabling remote monitoring by healthcare providers. This allows for real-time tracking of patient conditions and therapy effectiveness, thereby improving patient safety and outcomes.
There is a growing trend towards integrating telehealth services and remote monitoring technologies into home infusion therapies. This integration facilitates continuous patient monitoring without the need for frequent hospital visits. Digital health platforms enable healthcare providers to offer personalized support, adjust treatment plans in real time, and ensure compliance with therapy protocols, leading to better management of chronic conditions and enhanced patient satisfaction.
Emerging markets offer significant growth opportunities for home infusion therapy due to rising healthcare awareness, improving infrastructure, and increasing prevalence of chronic diseases. Countries in Asia-Pacific, Latin America, and the Middle East are investing in healthcare modernization and expanding home healthcare services. The growing elderly population in these regions further fuels demand for convenient, cost-effective treatment options. Companies can capitalize by introducing affordable, easy-to-use infusion devices and partnering with local healthcare providers to increase accessibility and adoption of home infusion therapies in underserved areas.
Share
Share
About Author
Ghanshyam Shrivastava - With over 20 years of experience in the management consulting and research, Ghanshyam Shrivastava serves as a Principal Consultant, bringing extensive expertise in biologics and biosimilars. His primary expertise lies in areas such as market entry and expansion strategy, competitive intelligence, and strategic transformation across diversified portfolio of various drugs used for different therapeutic category and APIs. He excels at identifying key challenges faced by clients and providing robust solutions to enhance their strategic decision-making capabilities. His comprehensive understanding of the market ensures valuable contributions to research reports and business decisions.
Ghanshyam is a sought-after speaker at industry conferences and contributes to various publications on pharma industry.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
